Kyung Bo Kim

The Tumor Inhibitor and Antiangiogenic Agent Withaferin A Targets the Intermediate Filament Protein Vimentin

Paola Bargagna‐Mohan, Adel Hamza, Yang-eon Kim et al. · Chemistry & Biology · 2007 · 346 citations

Life Sciences, Molecular Biology, Oncology +14

Crystal Structure of Epoxomicin:20S Proteasome Reveals a Molecular Basis for Selectivity of α‘,β‘-Epoxyketone Proteasome Inhibitors

M. Groll, Kyung Bo Kim, Norman Kairies et al. · Journal of the American Chemical Society · 2000 · 299 citations

Life Sciences, Biochemistry, Pharmacology +9

cGAS drives noncanonical-inflammasome activation in age-related macular degeneration

Nagaraj Kerur, Shin‐ichi Fukuda, Daipayan Banerjee et al. · Nature Medicine · 2017 · 294 citations · Full text

Medicine, Immunology, Ophthalmology +14

Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology

Ny Sin, Kyung Bo Kim, Mikael Elofsson et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 207 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +14

Lack of Proteasome Active Site Allostery as Revealed by Subunit-Specific Inhibitors

Jayhyuk Myung, Kyung Bo Kim, Kristina Lindsten et al. · Molecular Cell · 2001 · 120 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14